JP2021512903A5 - - Google Patents
Info
- Publication number
- JP2021512903A5 JP2021512903A5 JP2020542611A JP2020542611A JP2021512903A5 JP 2021512903 A5 JP2021512903 A5 JP 2021512903A5 JP 2020542611 A JP2020542611 A JP 2020542611A JP 2020542611 A JP2020542611 A JP 2020542611A JP 2021512903 A5 JP2021512903 A5 JP 2021512903A5
- Authority
- JP
- Japan
- Prior art keywords
- population
- cell populations
- treg
- tcon
- populations according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2024004747A JP7652949B2 (ja) | 2018-02-08 | 2024-01-16 | 同種造血幹細胞移植のための方法 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862628015P | 2018-02-08 | 2018-02-08 | |
| US62/628,015 | 2018-02-08 | ||
| PCT/US2019/017017 WO2019157158A2 (en) | 2018-02-08 | 2019-02-07 | Methods for allogenic hematopoietic stem cell transplantation |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024004747A Division JP7652949B2 (ja) | 2018-02-08 | 2024-01-16 | 同種造血幹細胞移植のための方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2021512903A JP2021512903A (ja) | 2021-05-20 |
| JP2021512903A5 true JP2021512903A5 (https=) | 2022-02-15 |
| JP7422667B2 JP7422667B2 (ja) | 2024-01-26 |
Family
ID=67549051
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020542611A Active JP7422667B2 (ja) | 2018-02-08 | 2019-02-07 | 同種造血幹細胞移植のための方法 |
| JP2024004747A Active JP7652949B2 (ja) | 2018-02-08 | 2024-01-16 | 同種造血幹細胞移植のための方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024004747A Active JP7652949B2 (ja) | 2018-02-08 | 2024-01-16 | 同種造血幹細胞移植のための方法 |
Country Status (10)
| Country | Link |
|---|---|
| US (5) | US11952588B2 (https=) |
| EP (2) | EP3749334B1 (https=) |
| JP (2) | JP7422667B2 (https=) |
| CN (1) | CN111971052B (https=) |
| AU (2) | AU2019218792A1 (https=) |
| CA (1) | CA3090175A1 (https=) |
| DK (1) | DK3749334T3 (https=) |
| ES (1) | ES3012854T3 (https=) |
| PL (1) | PL3749334T3 (https=) |
| WO (1) | WO2019157158A2 (https=) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3749334B1 (en) | 2018-02-08 | 2024-12-11 | The Board of Trustees of the Leland Stanford Junior University | Allogenic hematopoietic stem cell transplantation |
| WO2019165156A1 (en) | 2018-02-23 | 2019-08-29 | H. Lee Moffitt Cancer Center And Research Institute Inc. | Cd83-binding chimeric antigen receptors |
| AU2020333659A1 (en) * | 2019-08-16 | 2022-02-24 | H. Lee Moffitt Cancer Center And Research Institute Inc. | Anti-CD83 chimeric antigen receptor expressing t regulatory cells |
| CN117177748A (zh) * | 2020-11-04 | 2023-12-05 | 浩康生物系统公司 | 用于异基因造血干细胞移植的方法 |
| EP4240346A4 (en) * | 2020-11-04 | 2024-08-14 | Orca Biosystems, Inc. | PROCEDURES FOR ALLOGENEOUS TRANSPLANTATION OF HEMATOPOETIC STEM CELLS |
| AU2022245339A1 (en) * | 2021-03-25 | 2023-08-31 | Cellenkos, Inc. | Populations of enriched regulatory t cells and methods for producing same |
| WO2023081320A1 (en) * | 2021-11-04 | 2023-05-11 | Orca Biosystems, Inc. | Therapeutic compositions and methods for allogeneic hematopoietic stem cell transplantation |
| CA3248564A1 (en) * | 2022-04-15 | 2023-10-19 | Orca Biosystems, Inc. | METHODS FOR ALLOGENIC HEMATOPOIETIC STEM CELL TRANSPLANTATION |
| WO2024233788A2 (en) * | 2023-05-09 | 2024-11-14 | The Mclean Hospital Corporation | Intra-striatal co-transplantation of autologous treg and mda cells in parkinson's disease cell therapy |
Family Cites Families (37)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL107483A0 (en) | 1993-11-03 | 1994-02-27 | Yeda Res & Dev | Bone marrow transplantation |
| EP1461087A1 (en) * | 2001-12-06 | 2004-09-29 | Institut National De La Sante Et De La Recherche Medicale (Inserm) | Use of cd34+ hematopoietic progenitor cells for the treatment of cns disorders |
| JP4988172B2 (ja) * | 2005-06-24 | 2012-08-01 | 株式会社日立製作所 | 固体酸化物形燃料電池発電システム |
| US8916147B2 (en) | 2005-08-24 | 2014-12-23 | Yeda Research and Devolpment Co. Ltd. | Universal donor-derived tolerogenic cells for inducing non-syngeneic transplantation tolerance |
| US8632768B2 (en) | 2008-05-30 | 2014-01-21 | University Of Louisville Research Foundation, Inc. | Human facilitating cells |
| US11291686B2 (en) | 2008-05-30 | 2022-04-05 | University Of Louisville Research Foundation, Inc. | Human facilitating cells |
| WO2010022341A1 (en) | 2008-08-21 | 2010-02-25 | The United State Of America, As Represented By The Secretary, Department Of Health And Human Services | Methods of enriching and using regulatory t cells |
| AU2009311232B2 (en) | 2008-11-07 | 2014-10-30 | Sunnybrook Health Sciences Centre | Human progenitor T-cells |
| AU2010278702C1 (en) * | 2009-07-31 | 2016-07-14 | Forsyth Dental Infirmary For Children | Programming of cells for tolerogenic therapies |
| EP2378287A1 (en) | 2010-04-15 | 2011-10-19 | TXCell | New method for isolating Tr1 cells |
| JP2015504047A (ja) | 2011-12-22 | 2015-02-05 | イェダ リサーチ アンド デベロップメント カンパニー リミテッド | 安定かつ長期の生着のための併用療法 |
| US9233127B2 (en) | 2012-02-29 | 2016-01-12 | University Of Virginia Patent Foundation | Compositions and methods for CXCR4 signaling and umbilical cord blood stem cell engraftment |
| US20150110738A1 (en) | 2012-05-04 | 2015-04-23 | University Of Southern California | Methods and compositions for generating and using allogeneic suppressor cells |
| US9376663B2 (en) | 2013-04-02 | 2016-06-28 | New York University | GPR15-mediated homing and uses thereof |
| US11850592B2 (en) | 2017-11-13 | 2023-12-26 | Owl biomedical, Inc. | Particle manipulation system with multisort valve |
| CN105873952A (zh) * | 2013-10-31 | 2016-08-17 | 弗莱德哈钦森癌症研究中心 | 经修饰的造血干细胞/祖细胞和非t效应细胞及其用途 |
| EP3139957A4 (en) * | 2014-05-06 | 2018-04-25 | Scholar Rock, Inc. | Compositions and methods for growth factor modulation |
| RU2021118125A (ru) | 2014-12-29 | 2022-04-06 | Новартис Аг | Способы получения экспрессирующих химерный антигенный рецептор клеток |
| KR20250005465A (ko) | 2015-03-03 | 2025-01-09 | 키맵 리미티드 | 항체, 용도 및 방법 |
| CA2994241A1 (en) | 2015-07-31 | 2017-02-09 | University Of Florida Research Foundation, Inc. | Hematopoietic stem cells in combinatorial therapy with immune checkpoint inhibitors against cancer |
| CN108025023A (zh) | 2015-08-25 | 2018-05-11 | Uab研究基金会 | 用于干细胞移植的方法 |
| JP2018527932A (ja) | 2015-09-07 | 2018-09-27 | インセルム（インスティチュート ナショナル デ ラ サンテ エ デ ラ リシェルシェ メディカル） | ＣＤ８＋ＣＤ４５ＲＣｌｏｗ Ｔｒｅｇの新しい亜集団およびその使用 |
| CA3003923A1 (en) | 2015-11-05 | 2017-05-11 | Glycostem Therapeutics B.V. | Composition for use in immunotherapy |
| US20190032013A1 (en) | 2016-01-29 | 2019-01-31 | Tract Therapeutics, Inc. | Immune cell selection, expansion, and use |
| US10383895B2 (en) | 2016-02-18 | 2019-08-20 | Viera Bioscience, Inc. | Stimulation of therapeutic angiogenesis by T regulatory cells |
| CA3017743A1 (en) | 2016-03-14 | 2017-09-21 | Millennium Pharmaceuticals, Inc. | Method of preventing graft versus host disease |
| WO2018106610A1 (en) | 2016-12-05 | 2018-06-14 | The Regents Of The University Of California | Immunomagnetic bead-based method to enrich stem cells from whole hematopoietic tissue |
| MX2019010906A (es) | 2017-03-14 | 2020-02-12 | Juno Therapeutics Inc | Metodos para almacenamiento criogenico. |
| EP4417210A1 (en) | 2017-03-15 | 2024-08-21 | Orca Biosystems, Inc. | Compositions and methods for hematopoietic stem cell transplants |
| US11662343B2 (en) | 2017-04-07 | 2023-05-30 | The Council Of The Queensland Institute Of Medical Research | Cellular populations and uses thereof |
| EP3450981A1 (en) | 2017-08-28 | 2019-03-06 | Trizell GmbH | Btnl8 as a marker for tregs |
| EP3749334B1 (en) | 2018-02-08 | 2024-12-11 | The Board of Trustees of the Leland Stanford Junior University | Allogenic hematopoietic stem cell transplantation |
| WO2019178106A1 (en) | 2018-03-12 | 2019-09-19 | Medeor Therapeutics, Inc. | Methods for treating non-cancerous disorders using hematopoietic cells |
| US10842821B2 (en) | 2018-04-05 | 2020-11-24 | Medeor Therapeutics, Inc. | Cellular compositions derived from prior organ donors and methods of manufacture and use thereof |
| US10881692B2 (en) | 2018-04-05 | 2021-01-05 | Medeor Therapeutics, Inc. | Compositions for establishing mixed chimerism and methods of manufacture thereof |
| US20220305057A1 (en) | 2019-06-06 | 2022-09-29 | Medeor Therapeutics, Inc. | Methods of making cellular products by post- mortem mobilization and harvesting of hematopoietic cells |
| EP4240346A4 (en) | 2020-11-04 | 2024-08-14 | Orca Biosystems, Inc. | PROCEDURES FOR ALLOGENEOUS TRANSPLANTATION OF HEMATOPOETIC STEM CELLS |
-
2019
- 2019-02-07 EP EP19750722.1A patent/EP3749334B1/en active Active
- 2019-02-07 US US16/967,375 patent/US11952588B2/en active Active
- 2019-02-07 WO PCT/US2019/017017 patent/WO2019157158A2/en not_active Ceased
- 2019-02-07 CN CN201980024106.6A patent/CN111971052B/zh active Active
- 2019-02-07 JP JP2020542611A patent/JP7422667B2/ja active Active
- 2019-02-07 PL PL19750722.1T patent/PL3749334T3/pl unknown
- 2019-02-07 AU AU2019218792A patent/AU2019218792A1/en not_active Abandoned
- 2019-02-07 DK DK19750722.1T patent/DK3749334T3/da active
- 2019-02-07 EP EP24218671.6A patent/EP4529957A3/en active Pending
- 2019-02-07 ES ES19750722T patent/ES3012854T3/es active Active
- 2019-02-07 CA CA3090175A patent/CA3090175A1/en active Pending
-
2020
- 2020-09-24 US US17/031,187 patent/US20210002613A1/en not_active Abandoned
- 2020-09-24 US US17/031,213 patent/US11447747B2/en active Active
-
2022
- 2022-08-12 US US17/819,463 patent/US20220380729A1/en active Pending
-
2024
- 2024-01-16 JP JP2024004747A patent/JP7652949B2/ja active Active
- 2024-02-26 US US18/587,729 patent/US20240344027A1/en active Pending
-
2025
- 2025-11-19 AU AU2025271013A patent/AU2025271013A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021512903A5 (https=) | ||
| Kuzmina et al. | Multipotent mesenchymal stromal cells for the prophylaxis of acute graft‐versus‐host disease—a phase II study | |
| Chang et al. | Strategies for enhancing and preserving anti-leukemia effects without aggravating graft-versus-host disease | |
| Park et al. | Human umbilical cord blood cell grafts for brain ischemia | |
| Svobodova et al. | The role of mouse mesenchymal stem cells in differentiation of naive T-cells into anti-inflammatory regulatory T-cell or proinflammatory helper T-cell 17 population | |
| Sensebe et al. | Mesenchymal stem cells for clinical application | |
| JP6030114B2 (ja) | 放射線照射または化学物質による傷害を治療するための方法 | |
| Tolosa et al. | Mankind’s first natural stem cell transplant | |
| Moloudizargari et al. | The mechanisms of cellular crosstalk between mesenchymal stem cells and natural killer cells: Therapeutic implications | |
| Aversa et al. | The evolution of T cell depleted haploidentical transplantation | |
| Gao et al. | The immunosuppressive properties of non-cultured dermal-derived mesenchymal stromal cells and the control of graft-versus-host disease | |
| Bader et al. | Rapid immune recovery and low TRM in haploidentical stem cell transplantation in children and adolescence using CD3/CD19-depleted stem cells | |
| CN115137753A (zh) | 来自胎盘的自然杀伤细胞 | |
| Couban et al. | The case for plerixafor to replace filgrastim as the optimal agent to mobilize peripheral blood donors for allogeneic hematopoietic cell transplantation | |
| Locatelli et al. | Strategies to optimize the outcome of children given T-cell depleted HLA-haploidentical hematopoietic stem cell transplantation | |
| Ukrainskaya et al. | Haploidentical donor-derived memory CAR T cells: first in human experience and in vitro correlative study | |
| US20150374755A1 (en) | Treated Cells and Therapeutic Uses | |
| US20150174173A1 (en) | Stem cell treatment for radiation exposure | |
| JP6401445B2 (ja) | 造血幹細胞移植用の組合せ細胞製剤および生着促進剤並びにこれらの製造方法 | |
| Baiamonte et al. | Hematopoietic stem cell mobilization for gene therapy: the combination of G-CSF+ plerixafor in patients with beta-thalassemia major provides high yields of CD34+ cells with primitive signatures | |
| Lázár et al. | Difficulties of Mobilization and Harvesting of Hematopoietic Stem Cells in Heavily Pre-Treated Patients | |
| Kondo et al. | Guidelines on cell therapy | |
| Sedlmayr et al. | Generation of adherent lymphokine activated killer (A-LAK) cells from patients with acute myelogenous leukaemia | |
| Grazia et al. | Prolongation of cardiac allograft survival by a novel population of autologous CD117+ bone marrow-derived progenitor cells | |
| WO2024192172A1 (en) | Dendritic cell populations that inhibit gvhd |